Results 151 to 160 of about 931,164 (251)

Application of intensive care information system in clinical decision support

Huli yanjiu, 2016
尉俊铮, 王欣然, 王硕, 翟凤杰, 应波, 韩斌如, 费小璐, 王力红   +7 more
doaj  

Monitoring prostate cancer under androgen-deprivation therapy: insights from the implementation of a clinical decision support system dashboard. [PDF]

Front Oncol
Martínez-Pérez Á, Collantes G, Ruiz-Cerdá JL, Conde-Moreno A, Gironés R, Garcillán B, Amengual J, Gas ME.   +7 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Utility of a Smartphone-Based Clinical Decision Support System for Pressure Ulcer Management by Physicians: Randomized Crossover Pilot Study. [PDF]

JMIR Form Res
Ito T, Hirosawa T, Hayashi A, Yokose M, Shimizu T.   +4 more
europepmc   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

Policy, Financing, and Regulatory Barriers to Adopting AI-Powered Electrocardiography Interpretation Clinical Decision Support System in Ethiopia: A Qualitative Study. [PDF]

Int J Environ Res Public Health
Boltena MT, El-Khatib Z, Zewdie A, Springer P, Gebremedhn AT, Bukate TA, Fantaye YA, Mekoro M, Shargie MB, Kebede AS.   +9 more
europepmc   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Clinical Decision Support System, Antihypertensive Treatment Intensification, and Blood Pressure Control: A Post Hoc Secondary Analysis of a Cluster Randomized Trial.

JAMA Netw Open
Song J, Liu Y, Shang Q, Liu J, Zhang H, Zhou Z, Wang W, Lu J, Zheng X.   +8 more
europepmc   +1 more source

Process and Strategies for Implementing an Antenatal Psychosocial Clinical Decision Support System Within an Inter-Organisational Care Context: The Born in Belgium Professionals Platform. [PDF]

Healthcare (Basel)
Amuli K, Decabooter K, Germanes C, Van Parys AS, Verschelde S, Saey E, Moulin M, Cornu P, Beeckman K.   +8 more
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source